SNOA NASDAQ
Sonoma Pharmaceuticals, Inc.
1W: -2.4%
1M: -3.9%
3M: -0.8%
YTD: -65.9%
1Y: -67.9%
3Y: -92.2%
5Y: -98.8%
$1.24
-0.01 (-0.80%)
Weekly Expected Move ±4.7%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
17 relationships16
As Filer
counterparties named
1
As Counterparty
mentioned by others
4
Rel. Types
2021-03-31
Earliest Filing
2025-09-26
Latest Filing
partner: 9
customer: 4
licensee: 2
supplier: 1
Counterparties (Filed by SNOA)
16 relationshipsCompanies named in SNOA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Ladenburg Thalmann & Co. Inc. | — | partner | Entered into an At Market Issuance Sales Agreement to act as agent for the sale of the Company's common stock. | 2025-09-26 | View |
| WellSpring Pharmaceutical Corporation | — | customer | Entered into Master Supply Agreement and Amendment No. 1 for sale of Microcyn technology-based products. | 2025-03-25 | View |
| WellSpring Pharmaceutical Corporation | — | customer | Master Supply Agreement for sale of Microcyn technology-based products | 2025-01-30 | View |
| Medline Industries, LP | MDLN | partner | Distribution partner for wound care products in the US and Canada | 2024-10-22 | View |
| Medline Industries, LP | MDLN | partner | Distribution agreement for marketing and distribution of wound care products. | 2024-08-21 | View |
| Maxim Group LLC | MMS | partner | Sales agent/principal for equity distribution agreement | 2024-03-08 | View |
| NovaBay Pharmaceuticals, Inc. | NBY | partner | License and distribution agreement for Avenova-branded products in the European Union | 2024-01-09 | View |
| Maxim Group LLC | MMS | partner | Sales agent for equity distribution agreement | 2023-12-18 | View |
| Ladenburg Thalmann & Co. Inc. | — | partner | Sales agent for At-The-Market Offering Agreement amendment | 2023-02-24 | View |
| Ladenburg Thalmann & Co. Inc. | — | partner | Sales agent for At-The-Market Offering Agreement | 2022-12-23 | View |
| Sonoma Pharmaceuticals, Inc. | SNOA | supplier | Manufacturer of hypochlorous-acid based products supplying the Distributor. | 2022-01-20 | View |
| Salus Medical, LLC | — | customer | Distributor appointed to non-exclusively distribute the Products in the United States. | 2022-01-20 | View |
| Sonoma Pharmaceuticals, Inc. | SNOA | licensee | Licensor of the Product and Trademarks in the Exclusive License and Distribution Agreement | 2021-11-09 | View |
| Dyamed Biotech Pte, Ltd. | — | licensee | Licensee and exclusive distributor of the Product in the Territory | 2021-11-09 | View |
| H.C. Wainwright & Co., LLC | — | partner | Sales agent for the At-The-Market Offering Agreement | 2021-07-30 | View |
| EMC Pharma, LLC | — | customer | Exclusive distributor of Sonoma Pharmaceuticals' Microcyn technology products in the United States. | 2021-03-31 | View |
Mentioned As Counterparty
1 mentionsOther companies that named SNOA in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-17 | Shareholder Vote | View | |
| 2026-08-19 | Shareholder Vote | View | |
| 2026-06-18 | Other Events; Exhibits | View | |
| 2026-04-30 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-04-09 | Material Agreement; Exhibits | Agreement | View |
| 2026-01-28 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-01-12 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-02 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-10-23 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-10-09 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-09-29 | Other Events; Financial Statements and Exhibits | View | |
| 2025-09-26 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-08-29 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-04-28 | Other Events; Financial Statements and Exhibits | View | |
| 2025-04-07 | Other Events; Financial Statements and Exhibits | View | |
| 2025-03-25 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-01-30 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-01-03 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-11-21 | Termination of Material Definitive Agreement | View | |
| 2024-10-22 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR